Shuffle for fans
Chatbot

The Daily Dose

Education

Our mission is to create easily digestible content (i.e. doses) that encourages others along their personal improvement journey. We understand and appreciate that time is a nonrenewable resource; therefore, we strive to create content that will (1) absorb easily, (2) encourage consistently, and (3)Read more

Popular episodes

063 | Do Your Job | We Need to Talk | Phillip Van Hooser | The Daily Dose Podcast by Dose of Development

Oct 20 • 03:16

062 | Get Others Involved | We Need to Talk | Phillip Van Hooser | The Daily Dose Podcast by Dose of Development

Oct 19 • 03:27

061 | Work for Understanding | We Need to Talk | Phillip Van Hooser | The Daily Dose Podcast by Dose of Development

Oct 16 • 03:41

Unlike many baseball hats, communication with different people is not a “one size fits all.”...

060 | Tell the Truth | We Need to Talk | Phillip Van Hooser | The Daily Dose Podcast by Dose of Development

Oct 15 • 03:18

059 | Explain the Process | We Need to Talk | Phillip Van Hooser | The Daily Dose Podcast by Dose of Development

Oct 14 • 03:18

Think: How could explaining the process earlier help you communicate better?...

058 | Talk With People | We Need to Talk | Phillip Van Hooser | The Daily Dose Podcast by Dose of Development

Oct 13 • 03:35

057 | Enneagram | Type 9 Peacemaker | The Daily Dose Podcast by Dose of Development

Oct 12 • 02:47

#Enneagram Type 9: The Peacemaker...

056 | Enneagram | Type 8 Challenger | The Daily Dose Podcast by Dose of Development

Oct 9 • 02:58

055 | Enneagram | Type 7 Enthusiast | The Daily Dose Podcast by Dose of Development

Oct 8 • 02:34

054 | Enneagram | Type 6 Loyalist | The Daily Dose Podcast by Dose of Development

Oct 7 • 02:43

#Enneagram Type 6: The Loyalist...

Check out similar podcasts

Dans la Poche
Florian Beaufreton
苗炜|苗师傅读书会
苗炜|苗师傅读书会
The Viticole Podcast
Brian McClintic
Hangout with Makenpau
Guerrilla Podcast Syndicate
TwitterBlogCareersPress KitCommunity GuidelinesTerms of ServicePrivacy Policy
© 2021 Akora Labs, Inc.